# Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis

> **NCT04055389** · PHASE1 · WITHDRAWN · sponsor: **Jonathan Stine**

## Conditions studied

- Portal Vein Thrombosis
- Cirrhosis, Liver

## Interventions

- **DRUG:** Antithrombin III
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04055389
- **Lead sponsor:** Jonathan Stine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-01-01
- **Primary completion:** 2022-02-22
- **Final completion:** 2022-02-22
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Challenges with recruitment
- **Last updated:** 2022-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04055389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04055389, "Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04055389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*